Zobrazeno 1 - 10
of 42
pro vyhledávání: '"M C Sauerland"'
Autor:
S. M. Krauß, E. Telzerow, A. S. Moret, D. Richter, M. Rothenberg-Thurley, D. Görlich, M. C. Sauerland, W. E. Berdel, B. Wörmann, U. Krug, J. Braess, P. Heussner, W. Enard, W. Hiddemann, K. Spiekermann, U. Platzbecker, K. H. Metzeler
Publikováno v:
HemaSphere, Vol 6, Pp 316-317 (2022)
Externí odkaz:
https://doaj.org/article/19a6410b5a304b23907a3471b1ff3128
Autor:
S. Vosberg, A. Ohnmacht, C. Moser, A. Arneth, V. Jurinovic, K. H. Metzeler, M. C. Sauerland, D. Görlich, W. E. Berdel, J. Braess, S. Amler, U. Krug, W. Hiddemann, K. Spiekermann, C. C. Oakes, M. P. Menden, T. Herold, P. A. Greif
Publikováno v:
HemaSphere, Vol 6, Pp 378-379 (2022)
Externí odkaz:
https://doaj.org/article/789e32d18f7d411cb7e5f06426a60c93
Autor:
M Rothenberg-Thurley, S Amler, D Goerlich, T Köhnke, N P Konstandin, S Schneider, M C Sauerland, T Herold, M Hubmann, B Ksienzyk, E Zellmeier, S K Bohlander, M Subklewe, A Faldum, W Hiddemann, J Braess, K Spiekermann, K H Metzeler
Publikováno v:
Leukemia.
Some patients with acute myeloid leukemia (AML) who are in complete remission after induction chemotherapy harbor persisting pre-leukemic clones, carrying a subset of leukemia-associated somatic mutations. There is conflicting evidence on the prognos
Autor:
Frank Trösch, Michael Thomas, M. C. Sauerland, Michael Semik, C. Rübe, H. H. Scheld, Dorothea Riesenbeck, Normann Willich
Publikováno v:
Zeitschrift f�r Herz-, Thorax- und Gef��chirurgie. 14:38-43
Hintergrund: Beim lokal fortgeschrittenen nicht-kleinzelligen Bronchialkarzinom (NSCLC) im Stadium III ist die radikale Resektion im multimodalen Therapiekonzept prognoseentscheidend. Zur Klarung der Operationsstrategie und Radiotherapie ist ein akku
Autor:
E, Lengfelder, C, Haferlach, S, Saussele, T, Haferlach, B, Schultheis, S, Schnittger, W-D, Ludwig, P, Staib, C, Aul, A, Grüneisen, W, Kern, A, Reichle, H, Serve, W E, Berdel, J, Braess, K, Spiekermann, B, Wörmann, M-C, Sauerland, A, Heinecke, W, Hiddemann, R, Hehlmann, T, Büchner, W, Zschille
Publikováno v:
Leukemia. 23(12)
The objective of this study for newly diagnosed acute promyelocytic leukemia (APL) was to evaluate the efficacy of an intensified double induction chemotherapy including high dose ara-C (HD) and all-trans retinoic acid (ATRA) followed by consolidatio
Autor:
W, Kern, T, Haferlach, C, Schoch, M C, Sauerland, A, Heinecke, B, Wörmann, W, Berdel, Th, Büchner, W, Hiddemann
Publikováno v:
Annals of hematology. 83
Acute myeloid leukemia (AML) is a heterogeneous composition of biologically defined subgroups. Modern trials aim at developing subgroup-specific therapies. The German AML Cooperative Group 1999 trial asks three questions in a randomized factorial des
Autor:
J, Kienast, M, Stelljes, B, Berning, M, Kröger, M C, Sauerland, A, Heinecke, C, Schoch, B, Wörmann, T, Büchner, W, Hiddemann, W E, Berdel
Publikováno v:
Annals of hematology. 83
Allogeneic stem cell transplantation (allo-SCT) is considered the most potent postremission therapy for acute myeloid leukemia (AML). Its superior antileukemic activity is largely ascribed to the powerful graft-versus-leukemia (GvL) effects exerted b
Autor:
T, Büchner, W, Hiddemann, B, Wörmann, H, Löffler, W D, Ludwig, C, Schoch, T, Haferlach, G, Maschmeyer, P, Staib, C, Aul, G A, Heyll, A, Grüneisen, H, Rasche, J H, Eimermacher, L, Balleisen, H J, Pielken, H E, Reis, F, Griesinger, A, Reichle, M C, Sauerland, A, Heinecke
Publikováno v:
International journal of hematology. 72(3)
Maintenance treatment for patients with acute myeloid leukemia (AML) in remission has recently been controversially discussed and even abandoned by several groups. An analysis of 14 recently published multicenter trials, however, revealed the highest
Autor:
C, Schoch, T, Haferlach, D, Haase, C, Fonatsch, H, Löffler, B, Schlegelberger, P, Staib, M C, Sauerland, A, Heinecke, T, Büchner, W, Hiddemann
Publikováno v:
British journal of haematology. 112(1)
The clinical significance of complex chromosome aberrations for adults with acute myeloid leukaemia (AML) was assessed in 920 patients with de novo AML who were karyotyped and treated within the German AML Cooperative Group (AMLCG) trials. Complex ch
Autor:
E, Lengfelder, A, Reichert, C, Schoch, D, Haase, T, Haferlach, H, Löffler, P, Staib, A, Heyll, W, Seifarth, S, Saussele, C, Fonatsch, W, Gassmann, W D, Ludwig, A, Hochhaus, D, Beelen, C, Aul, M C, Sauerland, A, Heinecke, R, Hehlmann, B, Wörmann, W, Hiddemann, T, Büchner
Publikováno v:
Leukemia. 14(8)
A prospective multicenter study was performed to investigate the clinical and molecular results of intensified double induction therapy including high-dose cytarabine (ara-C) in combination with ATRA in newly diagnosed acute promyelocytic leukemia (A